MR. DAVID PAUL GOLDSTEIN, M.D.
Medical Practice at Zanker Rd, San Jose, CA
License number
California G12694
Category
Medical Practice
Type
Gynecology
Address
Address
2
3500 Zanker Rd, San Jose, CA 95134
1600 Ms 2-3 RM 205, Sacramento, CA 95814
1600 Ms 2-3 RM 205, Sacramento, CA 95814
Phone
(408) 451-6198
(916) 654-2431
(916) 654-3186 (Fax)
(916) 654-2431
(916) 654-3186 (Fax)
Personal information
See more information about DAVID PAUL GOLDSTEIN at radaris.comName
Address
Phone
498 Hawk Dr, Petaluma, CA 94954
50905 Avenida Bermudas, La Quinta, CA 92253
4536 Collett Ave, Encino, CA 91436
50 Quail, Portola Vally, CA 94028
5435 Woodman Ave, Sherman Oaks, CA 91401
Professional information
See more information about DAVID PAUL GOLDSTEIN at trustoria.com
Dr. David P Goldstein, San Jose CA - MD (Doctor of Medicine)
Dr. David P Goldstein, San Jose CA - MD (Doctor of Medicine)
Specialties:
Psychiatry, Obstetrics & Gynecology
Address:
1625 The Alameda SUITE 306, San Jose 95126
(650) 961-8923 (Phone), (408) 975-0764 (Fax)
3500 Zanker Rd, San Jose 95134
(408) 451-6198 (Phone)
(650) 961-8923 (Phone), (408) 975-0764 (Fax)
3500 Zanker Rd, San Jose 95134
(408) 451-6198 (Phone)
Languages:
English
Education:
Medical School
Thomas Jefferson University
Graduated: 1963
Mount Zion M C University Ca
Naval Reg Med Center
Stanford University Hospital
Thomas Jefferson University
Graduated: 1963
Mount Zion M C University Ca
Naval Reg Med Center
Stanford University Hospital
P38 Map Kinase Inhibitors
P38 Map Kinase Inhibitors
US Patent:
6479507, Nov 12, 2002
Filed:
Apr 19, 2001
Appl. No.:
09/839712
Inventors:
Soan Cheng - San Diego CA
David Michael Goldstein - San Jose CA
Teresa Alejandra Trejo Martin - Palo Alto CA
Eric Brian Sjogren - Mountain View CA
David Michael Goldstein - San Jose CA
Teresa Alejandra Trejo Martin - Palo Alto CA
Eric Brian Sjogren - Mountain View CA
Assignee:
Syntex (U.S.A.) LLC - Palo Alto CA
International Classification:
C07D49148
US Classification:
514301, 546114, 546115
Abstract:
The present invention relates to compounds of Formula (I) that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
Aminopyrrole Compounds
Aminopyrrole Compounds
US Patent:
6696471, Feb 24, 2004
Filed:
Aug 29, 2002
Appl. No.:
10/231792
Inventors:
David Michael Goldstein - San Jose CA
David Mark Rotstein - Sunnyvale CA
David Mark Rotstein - Sunnyvale CA
Assignee:
Syntex (U.S.A.) LLC - Palo Alto CA
International Classification:
A61K 3144
US Classification:
514343, 5462791
Abstract:
The present invention provides an aminopyrrole compound of the formula: a prodrug, individual isomer, a mixture of isomers or a pharmaceutically acceptable salt thereof, where R , R , Ar and Ar are those defined herein. The present invention also provides methods of using and preparing the aminopyrrole compounds of Formula I.
David Paul Goldstein, San Jose CA
David Paul Goldstein, San Jose CA
Specialties:
OB-GYN
Address:
3500 Zanker Rd, San Jose, CA 95134
Methods Of Inhibiting Btk And Syk Protein Kinases
Methods Of Inhibiting Btk And Syk Protein Kinases
US Patent:
7501410, Mar 10, 2009
Filed:
Mar 20, 2007
Appl. No.:
11/725752
Inventors:
David Michael Goldstein - San Jose CA, US
Matthias Rueth - Penzberg, DE
Matthias Rueth - Penzberg, DE
Assignee:
Roche Palo Alto LLC - Palo Alto CA
International Classification:
A61K 31/5377, A61K 31/502
US Classification:
5142328, 5142345, 514248
Abstract:
Methods of inhibiting a tyrosine kinase wherein said tyrosine kinase is BTK or SYK comprising administering to a patient in need thereof a therapeutically effective amount of a compound according to formula I are disclosed. The compounds are useful for treating auto-immune and inflammatory diseases.
P38 Map Kinase Inhibitors
P38 Map Kinase Inhibitors
US Patent:
6316464, Nov 13, 2001
Filed:
Oct 16, 1998
Appl. No.:
9/174299
Inventors:
Soan Cheng - San Diego CA
David Michael Goldstein - San Jose CA
Teresa Alejandra Trejo Martin - Palo Alto CA
Eric Brian Sjogren - Mountain View CA
David Michael Goldstein - San Jose CA
Teresa Alejandra Trejo Martin - Palo Alto CA
Eric Brian Sjogren - Mountain View CA
Assignee:
Syntex (U.S.A.) LLC - Palo Alto CA
International Classification:
A01N 4342
US Classification:
514300
Abstract:
The present invention relates to compounds of Formula (I) ##STR1##
that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
Imidazo-Substituted Compounds As P38 Kinase Inhibitors
Imidazo-Substituted Compounds As P38 Kinase Inhibitors
US Patent:
7081462, Jul 25, 2006
Filed:
May 4, 2005
Appl. No.:
11/122137
Inventors:
David Michael Goldstein - San Jose CA, US
Ronald Charles Hawley - Mountain View CA, US
Alfred Sui-Ting Lui - Redwood City CA, US
Eric Brian Sjogren - Mountain View CA, US
Ronald Charles Hawley - Mountain View CA, US
Alfred Sui-Ting Lui - Redwood City CA, US
Eric Brian Sjogren - Mountain View CA, US
Assignee:
Roche Palo Alto LLC - Palo Alto CA
International Classification:
C07D 487/14, A61K 31/519, A61P 19/02, A61P 25/28
US Classification:
514267, 544251
Abstract:
The present invention discloses compounds corresponding to formula I:.
6-Alkoxy-Pyrido-Pyrimidines
6-Alkoxy-Pyrido-Pyrimidines
US Patent:
7320987, Jan 22, 2008
Filed:
Mar 21, 2007
Appl. No.:
11/726339
Inventors:
David Michael Goldstein - San Jose CA, US
Julie Anne Lim - San Mateo CA, US
Julie Anne Lim - San Mateo CA, US
Assignee:
Roche Palo Alto LLC - Palo Alto CA
International Classification:
A01N 43/42, A61K 31/44
US Classification:
514299, 544279, 546122
Abstract:
The present invention provides compounds of the Formula I:.
7-Oxo-Pyridopyrimidines (Ii)
7-Oxo-Pyridopyrimidines (Ii)
US Patent:
2004019, Sep 30, 2004
Filed:
Apr 1, 2004
Appl. No.:
10/816554
Inventors:
Humberto Arzeno - Cupertino CA, US
Jian Chen - Santa Clara CA, US
James Dunn - Los Altos CA, US
David Goldstein - San Jose CA, US
Julie Lim - San Mateo CA, US
Jian Chen - Santa Clara CA, US
James Dunn - Los Altos CA, US
David Goldstein - San Jose CA, US
Julie Lim - San Mateo CA, US
Assignee:
Syntex (U.S.A.) LLC
International Classification:
A61K031/519, C07D487/02
US Classification:
514/264110, 544/280000
Abstract:
The present invention provides compounds of the formula:
a prodrug or a pharmaceutically acceptable salt thereof, wherein R, R, Rand Arare those defined herein, and methods for preparation and uses thereof.
Prediction Of Bone Marrow Toxicity
Prediction Of Bone Marrow Toxicity
US Patent:
2009020, Aug 20, 2009
Filed:
Feb 12, 2009
Appl. No.:
12/378437
Inventors:
Hans Marcus Ludwig Bitter - San Francisco CA, US
David Michael Goldstein - San Jose CA, US
Kyle Louis Kolaja - San Mateo CA, US
Henry Lin - Cupertino CA, US
Andrew James Olaharski - Sunnyvale CA, US
Hirdesh Uppal - Los Altos CA, US
David Michael Goldstein - San Jose CA, US
Kyle Louis Kolaja - San Mateo CA, US
Henry Lin - Cupertino CA, US
Andrew James Olaharski - Sunnyvale CA, US
Hirdesh Uppal - Los Altos CA, US
International Classification:
C12Q 1/48
US Classification:
435 15
Abstract:
The likelihood that a compound will exhibit bone marrow toxicity in an in vivo assay predicted by the ability of the compound to inhibit at least eight kinases from a selected group.